Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91

European Journal of Cancer

Volumn 45, Issue 7, 2009, Pages 1209-1217

  Hoff, Katja von ^a   Hinkes, Bernward ^a   Gerber, Nicolas U ^a   Deinlein, Frank ^a   Mittler, Uwe ^b   Urban, Christian ^c   Benesch, Martin ^c   Warmuth Metz, Monika ^a   Soerensen, Niels ^d   Zwiener, Isabella ^e   Goette, Heiko ^e   Schlegel, Paul G ^a   Pietsch, Torsten ^f   Kortmann, Rolf D ^g   Kuehl, Joachim ^a   Rutkowski, Stefan ^a,h  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b University Children's Hospital of Magdeburg   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d KLINIKUM OLDENBURG   (Germany)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^f UNIVERSITY OF BONN   (Germany)

^g UNIVERSITY OF LEIPZIG   (Germany)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Children; Medulloblastoma; Second neoplasm; Treatment outcome

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYTARABINE; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW SUPPRESSION; CACHEXIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEARING LOSS; HUMAN; LEUKOPENIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; METASTASIS; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUROPATHY; NEUROTOXICITY; OTOTOXICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDULLOBLASTOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; NEOPLASMS, SECOND PRIMARY; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 64049087816     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.01.015     Document Type: Article

References (31)

1. Kaatsch P., Rickert C.H., Kuhl J., Schuz J., and Michaelis J. Population-based epidemiologic data on brain tumors in German children. Cancer 92 12 (2001) 3155-3164
2. Tait D.M., Thornton-Jones H., Bloom H.J., Lemerle J., and Morris-Jones P. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26 4 (1990) 464-469
3. Evans A.E., Jenkin R.D., Sposto R., Ortega J.A., Wilson C.B., Wara W., et al. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72 4 (1990) 572-582
4. Bailey C.C., Gnekow A., Wellek S., Jones M., Round C., Brown J., et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 25 3 (1995) 166-178
5. Packer R.J., Gajjar A., Vezina G., Rorke-Adams L., Burger P.C., Robertson P.L., et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24 25 (2006) 4202-4208
6. Gajjar A., Chintagumpala M., Ashley D., Kellie S., Kun L.E., Merchant T.E., et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 7 10 (2006) 813-820
7. Verlooy J., Mosseri V., Bracard S., Tubiana A.L., Kalifa C., Pichon F., et al. Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study. Eur J Cancer 42 17 (2006) 3004-3014
8. Zeltzer P.M., Boyett J.M., Finlay J.L., Albright A.L., Rorke L.B., Milstein J.M., et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17 3 (1999) 832-845
9. Taylor R.E., Bailey C.C., Robinson K.J., Weston C.L., Walker D.A., Ellison D., et al. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer 41 5 (2005) 727-734
10. Kortmann R.D., Kuhl J., Timmermann B., Mittler U., Urban C., Budach V., et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT'91. Int J Radiat Oncol Biol Phys 46 2 (2000) 269-279
11. Chang C.H., Housepian E.M., and Herbert Jr. C. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93 6 (1969) 1351-1359
12. Taylor R.E., Bailey C.C., Robinson K., Weston C.L., Ellison D., Ironside J., et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study. J Clin Oncol 21 8 (2003) 1581-1591
13. Packer R.J., Goldwein J., Nicholson H.S., Vezina L.G., Allen J.C., Ris M.D., et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a children's cancer group study. J Clin Oncol 17 7 (1999) 2127-2136
14. Morris E.B., Gajjar A., Okuma J.O., Yasui Y., Wallace D., Kun L.E., et al. Survival and late mortality in long-term survivors of pediatric CNS tumors. J Clin Oncol 25 12 (2007) 1532-1538
15. Timmermann B., Kortmann R.D., Kuhl J., Meisner C., Slavc I., Pietsch T., et al. Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys 46 2 (2000) 287-295
16. Wolff J.E., Gnekow A.K., Kortmann R.D., Pietsch T., Urban C., Graf N., et al. Preradiation chemotherapy for pediatric patients with high-grade glioma. Cancer 94 1 (2002) 264-271
17. Kortmann R.D., Timmermann B., Kuhl J., Willich N., Flentje M., Meisner C., et al. HIT'91 (prospective, co-operative study for the treatment of malignant brain tumors in childhood): accuracy and acute toxicity of the irradiation of the craniospinal axis. Results of the quality assurance program. Strahlenther Onkol 175 4 (1999) 162-169
18. Packer R.J., Sutton L.N., Goldwein J.W., Perilongo G., Bunin G., Ryan J., et al. Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74 3 (1991) 433-440
19. Oyharcabal-Bourden V., Kalifa C., Gentet J.C., Frappaz D., Edan C., Chastagner P., et al. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French society of pediatric oncology study. J Clin Oncol 23 21 (2005) 4726-4734
20. Carrie C., Muracciole X., Gomez F., Habrand J.L., Benhassel M., Mege M., et al. Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol. Int J Radiat Oncol Biol Phys 63 3 (2005) 711-716
21. Packer R.J., Sutton L.N., Elterman R., Lange B., Goldwein J., Nicholson H.S., et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81 5 (1994) 690-698
22. Gajjar A., Sanford R.A., Bhargava R., Heideman R., Walter A., Li Y., et al. Medulloblastoma with brain stem involvement: the impact of gross total resection on outcome. Pediatr Neurosurg 25 4 (1996) 182-187
23. Merchant T.E., Wang M.H., Haida T., Lindsley K.L., Finlay J., Dunkel I.J., et al. Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era. Int J Radiat Oncol Biol Phys 36 1 (1996) 29-35
24. Miralbell R., Bieri S., Huguenin P., Feldges A., Morin A.M., Garcia E., et al. Prognostic value of cerebrospinal fluid cytology in pediatric medulloblastoma. Swiss pediatric oncology group. Ann Oncol 10 2 (1999) 239-241
25. Sanders R.P., Onar A., Boyett J.M., Broniscer A., Morris E.B., Qaddoumi I., et al. M1 medulloblastoma: high risk at any age. J Neurooncol (2008)
26. Rutkowski S., von Bueren A., von Hoff K., Hartmann W., Shalaby T., Deinlein F., et al. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91. Clin Cancer Res 13 9 (2007) 2651-2657
27. Yock T., Friedman H., Kun L., Kepner J., Barnes P., and Tarbell N. Response to pre-radiation chemotherapy is predictive of improved survival in high risk medulloblastoma: results from pediatric oncology group (POG 9031). Int J Radiat Oncol Biol Phys 51 3 (2001) 120-121
28. Lefkowitz I.B., Packer R.J., Ryan S.G., Shah N., Alavi J., Rorke L.B., et al. Late recurrence of primitive neuroectodermal tumor/medulloblastoma. Cancer 62 4 (1988) 826-830
29. Stavrou T., Bromley C.M., Nicholson H.S., Byrne J., Packer R.J., Goldstein A.M., et al. Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol 23 7 (2001) 431-436
30. Broniscer A., Ke W., Fuller C.E., Wu J., Gajjar A., and Kun L.E. Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude children's research hospital experience. Cancer 100 10 (2004) 2246-2252
31. Goldstein A.M., Yuen J., and Tucker M.A. Second cancers after medulloblastoma: population-based results from the United States and Sweden. Cancer Causes Control 8 6 (1997) 865-871